MGTX logo
MGTX NASDAQ US

MeiraGTx Holdings plc - Ordinary Shares

Healthcare · Biotechnology Website · IPO Jun 2018
$9.18
▲ +$0.09 (+0.99%)
Vol 1.1M
4
Quality Score
fail
Mkt Cap
$639.9M
ROE
-315.6%
Margin
-615.3%
D/E
2492.33
Beta
1.38
52W
$5–$10

Wall Street Consensus

14 analysts · Apr 2026
4
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
92.9%
Buy Rating

Price Chart

Similar Stocks

MNKD
MannKind Corp
P/E 60.5
$1.7B
JBIO
Jade Biosciences Inc
$709.8M
KURA
Kura Oncology Inc
$904.1M
VOR
Vor Biopharma Inc
$286.6M
SLS
Sellas Life Sciences Group Inc
$537.0M
SLDB
Solid Biosciences Inc
$439.4M
BBOT
BridgeBio Oncology Therapeutics Inc
P/E 212.3
$1.0B
REPL
Replimune Group Inc
$762.5M

Earnings

Beat rate: 40.0%
Next Report May 11, 2026
EPS Estimate: $-0.49
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.49 — —
Dec 2025 $-0.58 $0.19 +$0.77
Sep 2025 $-0.50 $-0.62 $-0.12
Jun 2025 $-0.48 $-0.48 $0.00

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -315.6% -241.9% -315.6% -315.6% -315.6% -315.6%
P/E (TTM) — — — — — —
Net Margin -1051.1% -484.9% -415.4% -415.4% -415.4% -615.3%
Gross Margin 27.5% — 26.6% 26.6% 26.6% 41.0%
D/E Ratio 2492.33 222.05 2492.33 2492.33 2492.33 2492.33
Current Ratio 0.88 1.53 0.88 0.88 0.88 0.22

Key Ratios

ROA (TTM)
-76.5%
P/S (TTM)
23.34
P/B
7.0
EPS (TTM)
$-2.11
CF/Share
$-2.29
Rev Growth 3Y
-4.1%
52W High
$9.73
52W Low
$4.55
$4.55 52-Week Range $9.73

How does MGTX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

MGTX AAPG ABEO ABOS ABP

MGTX valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
23.3
▲ 82% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
7.0
▲ 185% above peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

MGTX profitability vs Biotechnology peers

ROE
-315.6%
▼ 369% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-615.3%
▼ 115% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
41.0%
▼ 48% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-76.5%
▼ 64% below peers (-46.7%)
vs Peers
vs Industry
Weak

MGTX financial health vs Biotechnology peers

D/E ratio
2492.3
▼ 0% below peers (0.0)
vs Peers
vs Industry
High debt
Current ratio
0.2
▼ 95% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.4
▲ 42% above peers (1.0)
vs Peers
vs Industry
More volatile

MGTX fundamentals radar

MGTX Peer median Industry

MGTX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

MGTX vs peers: key metrics

Latest News

No related news yet